Cargando…
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer
SIMPLE SUMMARY: Arginase 1 and 2 are drivers of multiple immunosuppressive mechanisms and tumour-specific metabolic adaptations. Pharmacological inhibition of extracellular ARG1 has shown antitumour efficacy in various syngeneic tumour models, however, the importance of ARG2 as a therapeutic target...
Autores principales: | Grzybowski, Marcin Mikołaj, Stańczak, Paulina Seweryna, Pomper, Paulina, Błaszczyk, Roman, Borek, Bartłomiej, Gzik, Anna, Nowicka, Julita, Jędrzejczak, Karol, Brzezińska, Joanna, Rejczak, Tomasz, Güner-Chalimoniuk, Nazan Cemre, Kikulska, Agnieszka, Mlącki, Michał, Pęczkowicz-Szyszka, Jolanta, Olczak, Jacek, Gołębiowski, Adam, Dzwonek, Karolina, Dobrzański, Paweł, Zasłona, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406419/ https://www.ncbi.nlm.nih.gov/pubmed/36010962 http://dx.doi.org/10.3390/cancers14163967 |
Ejemplares similares
-
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
por: Dymek, Barbara, et al.
Publicado: (2022) -
A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment
por: Pilanc, Paulina, et al.
Publicado: (2021) -
Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma
por: Sklepkiewicz, Piotr, et al.
Publicado: (2023) -
Endogenous antimicrobial factors in the treatment of infectious diseases
por: Żelechowska, Paulina, et al.
Publicado: (2017) -
Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)